© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Although this is a serious public health threat, the CDC says the immediate risk to the American public is low.
One link between coronaviruses and the HIV drug Kaletra dates back to the 2003 outbreak of SARS.
William Matovu, an activist from Uganda, shares why U=U is so important to him and his advocacy.
Canadian researchers analyzed the reasons why people declined a nurse’s offer of PrEP.
An $80,000 grant from The Campbell Foundation will help scientist Natalia Freund continue her HIV vaccine studies.
It’s not just because of PrEP, which isn’t even easily available in England.
James Bushe challenged and overturned U.K. rules barring people with HIV from becoming commercial pilots.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
A South African study found that treating the virus within 48 hours or waiting up to two weeks led to comparable viral suppression rates.
A pair of studies focused on KwaZulu-Natal, South Africa.
Only HIV vax to show any efficacy prompted strong immune response in new study
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Meet Zee Strong and The Digital Living Quilt.
A long-term study found that kidney transplants between people with HIV have high success rates.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
